CELZ

Creative Medical Technology Holdings, Inc. [CELZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CELZ Stock Summary

Top 10 Correlated ETFs

CELZ


Top 10 Correlated Stocks

CELZ


In the News

12:06 29 Mar 2024 CELZ

Creative Medical (CELZ) Up on Orphan Drug Tag for CELZ-101

Creative Medical's (CELZ) CELZ-101 gets FDA's Orphan Drug designation for preventing allograft rejection in type-I diabetes patients undergoing pancreatic islet cell transplantation. Stock rises.

01:31 29 Mar 2024 CELZ

What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock

Creative Medical Technology Holdings, Inc. (CELZ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

01:39 29 Mar 2024 CELZ

Creative Medical (CELZ) Up 86% on Upbeat Diabetes Study Data

Creative Medical Technology (CELZ) reports positive one-year follow-up data from a study showing the efficacy of CELZ-001 in treating type II diabetes without any serious adverse effects.

06:00 29 Mar 2024 CELZ

3 Methods for Finding Penny Stocks to Buy and Hold

Use these strategies for making money with penny stocks in 2023 The post 3 Methods for Finding Penny Stocks to Buy and Hold appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

10:40 29 Mar 2024 CELZ

Why Is Creative Medical (CELZ) Stock Up 121% Today?

Creative Medical (NASDAQ: CELZ ) stock is rocketing higher on Wednesday thanks to clearance for a new clinical trial. That clearance comes from the FDA and covers CELZ-201 cell therapy.

09:38 29 Mar 2024 CELZ

Penny Stocks To Buy Now? 5 To Watch After News This Week

Stock Market News Has These Penny Stocks On Traders' Watch Lists This Week. The post Penny Stocks To Buy Now?

08:00 29 Mar 2024 CELZ

Penny Stocks to Watch as June Comes to an End

Are these penny stocks on your watchlist right now? The post Penny Stocks to Watch as June Comes to an End appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

11:27 29 Mar 2024 CELZ

Penny Stocks To Buy? 8 Short Squeeze Stocks To Watch Now

Short squeeze penny stocks to watch. The post Penny Stocks To Buy?

10:23 29 Mar 2024 CELZ

Best Penny Stocks To Buy Now? 5 Short Squeeze Stocks To Watch

Short squeeze penny stocks to watch right now. The post Best Penny Stocks To Buy Now?

03:17 29 Mar 2024 CELZ

Trending Penny Stocks to Buy Now, 3 to Watch During Trading in April

Check these three trending penny stocks out for your watchlist right now The post Trending Penny Stocks to Buy Now, 3 to Watch During Trading in April  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

CELZ Financial details

Company Rating
Neutral
Market Cap
7.17M
Income
-9.7M
Revenue
24.6K
Book val./share
8.45
Cash/share
8.37
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-0.68
Forward P/E
-1.25
PEG
0.27
P/S
259.57
P/B
0.55
P/C
0.62
P/FCF
-0.66
Quick Ratio
28.43
Current Ratio
28.6
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-6.87
EPS next Y
-4.17
EPS next Q
-1.14
EPS this Y
-59.17%
EPS next Y
-39.3%
EPS next 5Y
-167.39%
EPS last 5Y
-76.29%
Revenue last 5Y
-44.14%
Revenue Q/Q
-
EPS Q/Q
30.77%
-
-
-
-
SMA20
22.82%
SMA50
15.49%
SMA100
16.52%
Inst Own
2.32%
Inst Trans
0%
ROA
-78%
ROE
-69%
ROC
-0.84%
Gross Margin
67%
Oper. Margin
-41164%
Profit Margin
-39432%
Payout
-
Shs Outstand
1.36M
Shs Float
1.32M
-
-
-
-
Target Price
-
52W Range
3.93-13.3
52W High
-59.92%
52W Low
+73.67%
RSI
52.64
Rel Volume
0.07
Avg Volume
214.22K
Volume
14.67K
Perf Week
1.36%
Perf Month
19.77%
Perf Quarter
5.25%
Perf Half Y
-2.8%
-
-
-
-
Beta
4.946
-
-
Volatility
0.1%, 0.74%
Prev Close
1.17%
Price
5.21
Change
0.58%

CELZ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
80.032.840.270.080.01
Net income per share
-5.02K-648.145.97-9.21-3.76
Operating cash flow per share
-586.6-7.5-6.82-7.15-5.7
Free cash flow per share
-586.6-11.81-6.82-7.15-5.7
Cash per share
42.871.6933.0126.112.46
Book value per share
-3.9K-686.931.4514.547.35
Tangible book value per share
-4.11K-697.5929.8314.157.35
Share holders equity per share
-3.9K-686.931.4514.547.35
Interest debt per share
1.43K34.8313.17-0.090
Market cap
465.3K8.05M7.18M4.16M6.49M
Enterprise value
1.44M8.75M-3.54M-14.24M3.02M
P/E ratio
-0.04-0.210.48-0.41-1.23
Price to sales ratio
2.8148.9681.8146.91721.02
POCF ratio
-0.38-18.53-3.24-0.53-0.81
PFCF ratio
-0.38-11.77-3.24-0.53-0.81
P/B Ratio
-0.06-0.20.70.260.63
PTB ratio
-0.06-0.20.70.260.63
EV to sales
8.6953.16-40.39-160.76335.81
Enterprise value over EBITDA
-1.3-8.341.171.42-0.55
EV to operating cash flow
-1.19-20.121.61.83-0.38
EV to free cash flow
-1.19-12.771.61.83-0.38
Earnings yield
-22.31-4.662.08-2.42-0.81
Free cash flow yield
-2.61-0.08-0.31-1.88-1.24
Debt to equity
-0.13-0.02000
Debt to assets
21.1000
Net debt to EBITDA
-0.88-0.663.531.830.63
Current ratio
0.01010.225.6427.65
Interest coverage
-0.6-0.91-0.73102.110
Income quality
0.140.01-0.120.771.52
Dividend Yield
000.6700
Payout ratio
000.3200
Sales general and administrative to revenue
7.390000
Research and developement to revenue
001.2470.75218.96
Intangibles to total assets
0.820.860.050.020
Capex to operating cash flow
00.58000
Capex to revenue
0-1.52000
Capex to depreciation
0-3.74000
Stock based compensation to revenue
01.046.780.784.07
Graham number
20.99K3.16K180.3654.8924.92
ROIC
0.20.03-0.24-0.64-0.53
Return on tangible assets
-110.13-383.171.39-0.54-0.49
Graham Net
-4.11K-697.5929.816.142.2
Working capital
-8.51M-40.42M9.69M15.43M9.9M
Tangible asset value
-8.51M-40.42M9.69M15.43M10.34M
Net current asset value
-8.51M-40.42M9.69M15.43M9.9M
Invested capital
-0.13-0.02000
Average receivables
7.6K2.8K1.24K-5.04M-5.04M
Average payables
326.31K335.84K556.38K2.01M1.79M
Average inventory
005.43K10.53K8.39K
Days sales outstanding
12.35010.34-41.52K0
Days payables outstanding
2.57K2.53K5.8K41.86K32.17K
Days of inventory on hand
0082.71130.6668.56
Receivables turnover
29.55035.31-0.010
Payables turnover
0.140.140.060.010.01
Inventory turnover
004.412.790.55
ROE
1.290.941.46-0.63-0.51
Capex per share
0-4.31000

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.040.01000
Net income per share
-0.67-4.37-0.7-0.78-1.02
Operating cash flow per share
-0.62-2.55-2.73-0.7-0.91
Free cash flow per share
-0.62-2.55-2.73-0.7-0.91
Cash per share
19.2520.2310.349.638.37
Book value per share
15.7311.2710.539.748.45
Tangible book value per share
15.410.9610.249.468.12
Share holders equity per share
15.7311.2710.539.748.45
Interest debt per share
0.03-0.04000
Market cap
6.17M5.36M7.04M6.54M7.04M
Enterprise value
-15.82M-13.04M-2.48M2.55M2.54M
P/E ratio
-1.63-0.22-1.78-1.48-1.21
Price to sales ratio
112.27288.34001.17K
POCF ratio
-7.07-1.49-1.83-6.63-5.4
PFCF ratio
-7.07-1.49-1.83-6.63-5.4
P/B Ratio
0.280.340.470.480.58
PTB ratio
0.280.340.470.480.58
EV to sales
-287.56-700.8700422.58
Enterprise value over EBITDA
16.492.112.41-2.18-1.67
EV to operating cash flow
18.113.630.65-2.59-1.94
EV to free cash flow
18.113.630.65-2.59-1.94
Earnings yield
-0.15-1.15-0.14-0.17-0.21
Free cash flow yield
-0.14-0.67-0.55-0.15-0.19
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
22.922.979.253.412.96
Current ratio
55.445.6436.3534.4628.6
Interest coverage
-26.79100.86-22.26K00
Income quality
0.890.583.650.90.9
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
4.2288.6100165.45
Intangibles to total assets
0.020.020.030.030.04
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
0.170.49001.53
Graham number
15.4333.312.9113.0913.89
ROIC
-0.04-0.39-0.07-0.09-0.13
Return on tangible assets
-0.04-0.33-0.07-0.08-0.12
Graham Net
16.2912.510.069.358.07
Working capital
21.61M15.43M14.41M13.34M11.62M
Tangible asset value
21.61M15.43M14.41M13.34M11.63M
Net current asset value
21.61M15.43M14.41M13.34M11.62M
Invested capital
00000
Average receivables
-2.51M-7.55M-5.04M0.50
Average payables
319.26K1.8M1.81M348.92K355.73K
Average inventory
18.26K13.04K10.19K10.19K8.99K
Days sales outstanding
-8.22K-48.77K000
Days payables outstanding
1.84K51.59K1.38K1.35K13.76K
Days of inventory on hand
89.4160.9639.8539.85292.28
Receivables turnover
-0.010000
Payables turnover
0.0500.070.070.01
Inventory turnover
1.010.562.262.260.31
ROE
-0.04-0.39-0.07-0.08-0.12
Capex per share
00000

CELZ Frequently Asked Questions

What is Creative Medical Technology Holdings, Inc. stock symbol ?

Creative Medical Technology Holdings, Inc. is a US stock , located in Phoenix of Az and trading under the symbol CELZ

What is Creative Medical Technology Holdings, Inc. stock quote today ?

Creative Medical Technology Holdings, Inc. stock price is $5.21 today.

Is Creative Medical Technology Holdings, Inc. stock public?

Yes, Creative Medical Technology Holdings, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap